Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,009.00
+9.50 (0.95%)
Oct 23, 2025, 3:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.46M INR
Profits / Employee
1.64M INR
Market Cap
1.02T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
| Glenmark Pharmaceuticals | 15,800 |
Zydus Lifesciences News
- 17 days ago - Zydus Lifesciences receives Health Canada approval for Liothyronine tablets 5 mcg and 25 mcg - Business Upturn
- 17 days ago - Zydus Lifesciences gets USFDA nod for Deflazacort oral suspension - Business Upturn
- 23 days ago - Zydus Lifesciences extends closing date for acquisition of Sterling Biotech’s API business - Business Upturn
- 27 days ago - Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street - The Times of India
- 27 days ago - Zydus Lifesciences shares slip nearly 3% as Trump’s pharma tariff rattles sector - Business Upturn
- 5 weeks ago - Zydus Lifesciences’ ZyVet launches first veterinary-approved generic of Furosemide tablets - Business Upturn
- 5 weeks ago - Zydus Lifesciences’ ZyVet launches first FDA-approved generic treatment for canine urinary incontinence - Business Upturn
- 6 weeks ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga